News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
EORTC successfully completed the prospective recruitment for the SPECTA IMMUcan cohort with 1,472 patients in total
EORTC/X
Nov 2, 2024, 19:35

EORTC successfully completed the prospective recruitment for the SPECTA IMMUcan cohort with 1,472 patients in total

EORTC shared a post on LinkedIn:

“We are thrilled to announce that as of 30 October, we have successfully completed the prospective recruitment for the EORTC SPECTA IMMUcan cohort with 1,472 patients in total.

This incredible journey began five years ago with the enrollment of our first patient in June 2019.

Thanks to external collaborations, the total number of patients analysed in IMMUcan will reach 2,650, all of whom will undergo comprehensive molecular and cellular profiling.

The analysis of all the generated data will continue next year. Stay tuned for more updates.”

EORTC successfully completed the prospective recruitment for the SPECTA IMMUcan cohort with 1,472 patients in total

cancer EORTC IMMUcan OncoDaily Oncology SPECTA
Special Coverage
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer